Summary

The innovation cycle in regenerative medicine starts with patient needs and research: new innovations in basic and biomaterial sciences and stem cell research are as a result of the network rapidly transferred to clinic, where new insight is gained on their applicability, disease pathomechanims and attempts to repair, which feed productive and accelerating cycles of innovations, testing, feedback and new innovations, leading to clinical applications. Regenerative medicine also increases understanding of normal healing and helps to develop strategies for primary prophylaxis against e.g. cardiovascular and musculoskeletal diseases. These unmet needs represent a great potential market for new products promoted by our SEM company partners. The idea is to expand the network at its base (basic research) and top (clinical translation, technology transfer), in part perhaps with organizations like Steinbeis Foundation.

The REMEDIC network at the node point facilitates up- and downward transfer of knowledge and know-how, but has an even more significant interface towards the scientific, public health and society interfaces. Developmental bottle necks, such as lack of clean space facilities, are identified and resources located. Dissemination occurs via rotating European-wide workshops and schools, which form the building blocks of the dynamic REMEDIC website and the basis for a Master Course. Keynote discussants in each meeting invite 2-3 hospital and health authorities and representative of public health organizations as their personal guests to a VIP dinner table organized in association to the meetings.

Duration

Five years, from May 2007 to April 2013